Team:BCCS-Bristol/Project

From 2009.igem.org

(Difference between revisions)

Latest revision as of 03:54, 22 October 2009

BCCS-Bristol
iGEM 2009


Wet Lab	Modelling
Click above to read more about our wet-lab work.	Click above to read more about our team's modelling approach and the simulations we performed to assess the effectiveness of OMV based communication.

Project description

The known and hypothesized roles of Gram-negative OMVs [4]

Our aim was to construct a system for directed delivery of proteins into cells by outer membrane vesicle (OMV) protein secretion. Gram-negative bacteria naturally produce outer member vesicles (OMVs): spherical, bilayered proteolipids from 20-200nm in diameter. OMVs can carry outer membrane, periplasmic and cytoplasmic proteins, DNA, RNA and other factors associated with virulence. They have been implicated in the delivery of toxins to host cells, in the transfer of proteins and genetic materials between bacterial cells and in cell-to-cell signalling [2]. Synthetic biology offers the potential to engineer these mechanisms for human benefit, for example, the injection of toxic cocktails of proteins into cancerous cells or the replacement of proteins missing as a result of genetic defects [3]. These systems may be further enhanced by localised delivery of OMVs, for example, via the control of magnetotactic bacteria using external magnetic fields [5].

We designed Biobricks with the potential to allow the secretion of any protein in OMVs via fusion with novel, non-toxic partners known to be enhanced in OMVs, like FhuA and OsmE proteins. We hope that the Biobricks will become widely used as a simple and effective means of protein secretion, whilst also conveying the unique engineering advantages of vesicular encapsulation. In order to allow easy protein fusions we designed and created a new protein fusion assembly standard, [http://hdl.handle.net/1721.1/49505 RFC44], that provides the basis of a solution to a biobrick-friendly protein fusion mechanism that supports the current favorite assembly standard 10 (RFC10) and hence allows utilization of most of the current biobricks database.

The modelling team continued work on BSim, the agent-based modelling framework started by last year's Bristol team. A slew of new features were added and the package was made much more extensible to the point that we believe BSim has a realistic chance of becoming the tool of choice for simulation of interacting bacterial populations. BSim was used to study simultaneous delivery of proteins into cells via packaging in OMVs and several other scenarios unrelated to vesicles, demonstrating its flexibility.

References

[1] https://2008.igem.org/Team:BCCS-Bristol/Modeling, true 30th July 2009

[2] Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli, [http://dx.doi.org/doi:10.1002/pmic.200700196 doi:10.1002/pmic.200700196]

[3] Engineered Bacterial Outer Membrane Vesicles with Enhanced Functionality, [http://dx.doi.org/doi:10.1016/j.jmb.2008.03.076 doi:10.1016/j.jmb.2008.03.076]

[4] Special delivery: vesicle trafficking in prokaryotes, [http://dx.doi.org/doi:10.1111/j.1365-2958.2006.05272.x doi:10.1111/j.1365-2958.2006.05272.x]

[5] Controlled manipulation and actuation of micro-objects with magnetotactic bacteria, [http://dx.doi.org/doi:10.1063/1.2402221 doi:10.1063/1.2402221]

@@ Line 2: / Line 2: @@
 <html>
-<img src="http://dl.getdropbox.com/u/634020/bccs_igem_logo.jpg" />
+<center>
-<img style="width:750px" src="http://dl.getdropbox.com/u/634020/bccs_igem_banner.png" >
+<img style="width:750px" src="https://static.igem.org/mediawiki/2009/thumb/e/ed/BCCS_igem_banner.png/800px-BCCS_igem_banner.png" >
+</center>
 </html>
-<html>
-<h1>VESECURE</h1>
-</html>
-{|align = "center" width = "60%"
+{| class="panel" align = "center" width = "60%"
 |-
-|width="25%" padding="3px"| <html><center><a href="https://2009.igem.org/Team:BCCS-Bristol/Project/Wet_lab"><img src="http://dl.getdropbox.com/u/634020/wetlabl_button.jpg"></a></center></html>
+|width="25%" padding="3px"| <html><center><a href="https://2009.igem.org/Team:BCCS-Bristol/Project/Wet_lab"><img src="https://static.igem.org/mediawiki/2009/b/b6/BCCS_Wetlabl_button.jpg"></a></center></html>
-|width="25%" padding="3px"| <html><center><a href="https://2009.igem.org/Team:BCCS-Bristol/BSim/Case_studies/VESECURE"><img src="http://dl.getdropbox.com/u/634020/modelling_button.jpg"></a></center></html>
+|width="25%" padding="3px"| <html><center><a href="https://2009.igem.org/Team:BCCS-Bristol/Project/Modelling"><img src="https://static.igem.org/mediawiki/2009/4/48/BCCS_Modelling_button.jpg"></a></center></html>
 |-
 |width="50%"|<center>[[Team:BCCS-Bristol/Project/Wet_lab|Wet Lab]]</center>
-|width="50%"|<center>[[Team:BCCS-Bristol/BSim/Case_studies/VESECURE|Modelling]]</center>
+|width="50%"|<center>[[Team:BCCS-Bristol/Project/Modelling|Modelling]]</center>
 |-
+|Click above to read more about our wet-lab work.
 |Click above to read more about our team's modelling approach and the simulations we performed to assess the effectiveness of OMV based communication.
-|Click above to read more about our wet-lab work .
 |-
 |}
@@ Line 28: / Line 26: @@
 [[Image:BCCS-Bristol_vesicles.jpg|thumb|The known and hypothesized roles of Gram-negative OMVs [4]]]
+Our aim was to construct a system for directed delivery of proteins into cells by outer membrane vesicle (OMV) protein secretion. Gram-negative bacteria naturally produce outer member vesicles (OMVs): spherical, bilayered proteolipids from 20-200nm in diameter. OMVs can carry outer membrane, periplasmic and cytoplasmic proteins, DNA, RNA and other factors associated with virulence. They have been implicated in the delivery of toxins to host cells, in the transfer of proteins and genetic materials between bacterial cells and in cell-to-cell signalling [2].  Synthetic biology offers the potential to engineer these mechanisms for human benefit, for example, the injection of toxic cocktails of proteins into cancerous cells or the replacement of proteins missing as a result of genetic defects [3]. These systems may be further enhanced by localised delivery of OMVs, for example, via the control of magnetotactic bacteria using external magnetic fields [5].
+We designed [https://2009.igem.org/Team:BCCS-Bristol/Project/Wet_lab/BioBricks Biobricks] with the potential to allow the secretion of any protein in OMVs via fusion with novel, non-toxic partners known to be enhanced in OMVs, like FhuA and OsmE proteins. We hope that the Biobricks will become widely used as a simple and effective means of protein secretion, whilst also conveying the unique engineering advantages of vesicular encapsulation. In order to allow easy protein fusions we designed and created a new protein fusion assembly standard, [http://hdl.handle.net/1721.1/49505 RFC44], that provides the basis of a solution to a biobrick-friendly protein fusion mechanism that supports the current favorite assembly standard 10 (RFC10) and hence allows utilization of most of the current biobricks database.
-We aim to construct a system for directed delivery of proteins into cells by outer membrane vesicle (OMV) protein secretion. Lab work will be informed by an enhanced version of the BSim agent-based modelling framework [1], with a greatly expanded feature set and increased biological realism.
-Gram-negative bacteria naturally produce outer member vesicles (OMVs): spherical, bilayered proteolipids from 20-200nm in diameter. OMVs can carry outer membrane, periplasmic and cytoplasmic proteins, DNA, RNA and other factors associated with virulence. They have been implicated in the delivery of toxins to host cells, in the transfer of proteins and genetic materials between bacterial cells and in cell-to-cell signalling [2].  Synthetic biology offers the potential to engineer these mechanisms for human benefit, for example, the injection of toxic cocktails of proteins into cancerous cells or the replacement of proteins missing as a result of genetic defects [3]. These systems may be further enhanced by localised delivery of OMVs, for example, via the control of magnetotactic bacteria using external magnetic fields [5].
+The modelling team continued work on [https://2009.igem.org/Team:BCCS-Bristol/BSim BSim], the agent-based modelling framework started by last year's Bristol team. A slew of new features were added and the package was made much more extensible to the point that we believe BSim has a realistic chance of becoming the tool of choice for simulation of interacting bacterial populations. BSim was used to study simultaneous delivery of proteins into cells via packaging in OMVs and several other scenarios unrelated to vesicles, demonstrating its flexibility.
-We intend to design Biobricks allowing the secretion of any protein in OMVs via fusion with novel, non-toxic partners known to be enhanced in OMVs. We hope that the Biobricks will become widely used as a simple and effective means of protein secretion, whilst also conveying the unique engineering advantages of vesicular encapsulation.
-The mechanisms of magnetotaxis and OMV secretion will be implemented into BSim, the award-winning modelling framework developed by last year’s Bristol team, to assist in experimental design and to test speculative ideas.  Another key new feature will allow users to ‘plug in’ gene regulatory network models and see their effect at the population level.
 == References ==